Gynecology

The first clinical trial of uterus transplantation in the United States has begun at Cleveland Clinic in Ohio.  

Olá, pessoal! Esta é uma música baseada no glorioso castelo Rá-Tim-Bum. Tema - Técnica operatória da Histerectomia Vaginal Pra quem ficou curioso, Paola é mi...  

Peter Kovacs reviews a new guideline from the American Society for Reproductive Medicine on the issue of subclinical hypothyroidism in women trying to become pregnant.  

One large (n=1528), open-label, randomised controlled trial (RCT; ICON7) that assessed the efficacy and safety of bevacizumab 7.5 mg/kg for treating ovarian cancer was identified; quality of life outcomes from this study were also reported separately (Stark et al. 2013). ICON7 found that interim analysis of overall survival data showed no benefit for adding bevacizumab to standard chemotherapy compared with standard chemotherapy alone, except in a subgroup deemed at high risk for progression. In this subgroup median results for progression-free survival after a median follow-up of 19 months were 10.5 months with standard chemotherapy and 15.9 months with standard chemotherapy plus bevacizumab. Adding bevacizumab to standard chemotherapy resulted in a small but clinically relevant reduction in quality of life.  

This guideline will shortly be checked to see if it needs updating, please register as a stakeholder to be informed about the decision.  

NICE has developed a Medtech Innovation Briefing (MIB) on ZedScan as an adjunct to colposcopy in women with suspected cervical intra epithelial neoplasia.